Skip to content
OpenCapital
Get started

Cytosorbents CTSO Q4 2024 Annual earnings

Reported March 31, 2025 · After market close

Revenue$6.5MMiss by $3.6MDiluted EPS-$0.03Beat by $0.04
Revenue estimate$10.1M
EPS estimate-$0.07

Next report

Aug 6, 2026 (In 3 weeks)
Revenue estimate$9.4M
EPS estimate-$0.05

Versus estimates

Revenue

Q1 2026$8.9MMiss by $536.0KQ4 2025$9.2MMiss by $546.0KQ3 2025$9.5MBeat by $270.0KQ2 2025$9.6MBeat by $395.3KQ1 2025$8.7MMiss by $280.3K
Q4 2024$6.5MMiss by $3.6M

Diluted EPS

Q1 2026-$0.08Miss by $0.02Q4 2025-$0.09Miss by $0.04Q3 2025-$0.04Beat by $0.02Q2 2025-$0.05Beat by $0.02Q1 2025-$0.06Beat by $0.02
Q4 2024-$0.03Beat by $0.04

Ask the moment Cytosorbents reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Cytosorbents report Q4 2024 earnings?
Cytosorbents (CTSO) reported Q4 2024 earnings on March 31, 2025 after market close.
What were Cytosorbents's Q4 2024 revenue and EPS?
Cytosorbents reported revenue of $6.5M and diluted EPS of $-0.03 for Q4 2024.
Did Cytosorbents beat estimates in Q4 2024?
Revenue missed the consensus estimate of $10.1M by $3.6M. EPS beat the consensus estimate of $-0.07 by $0.04.
Where can I find Cytosorbents's Q4 2024 SEC filings?
You can read the 10-K periodic report (0001410578-25-000591) directly on SEC EDGAR. The filing index links above go to sec.gov.